Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer

NCT00005980 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

116

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: pegylated liposomal doxorubicin hydrochloride

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC